Literature DB >> 20459442

Associations of risk factors obesity and occupational airborne exposures with CDKN2A/p16 aberrant DNA methylation in esophageal cancer patients.

S Mohammad Ganji1, E Miotto, E Callegari, K Sayehmiri, F Fereidooni, M Yazdanbod, F Rastgar-Jazii, M Negrini.   

Abstract

It is known that obesity and occupational airborne exposure such as dust are among risk factors of esophageal cancer development, in particular squamous cell carcinoma (SCC) of esophagus. Here, we tested whether these factors could also affect aberrant DNA methylation. DNAs from 44 fresh tumor tissues and 19 non-tumor adjacent normal tissues, obtained from 44 patients affected by SCC of esophagus (SCCE), were studied for methylation at the CDKN2A/p16 gene promoter by methylation-specific polymerase chain reaction assay. Statistical methods were used to assess association of promoter methylation with biopathological, clinical, and personal information data, including obesity and airborne exposures. Methylation at the CDKN2A/p16 gene promoter was detected in 12 out of 44 tumor samples. None of the non-tumor tissues exhibited the aberrant methylation. Our results confirmed previously described significant association with low tumor stage (P= 0.002); in addition, we found that obesity (P= 0.001) and occupational exposure (P= 0.008) were both significantly associated with CDKN2A/p16 promoter methylation. This study provides evidence that obesity and occupational exposure increase the risk of developing esophageal cancer through an enhancement of CDKN2A/p16 promoter methylation.
© 2010 Copyright the Authors. Journal compilation © 2010, Wiley Periodicals, Inc. and the International Society for Diseases of the Esophagus.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20459442     DOI: 10.1111/j.1442-2050.2010.01059.x

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  5 in total

Review 1.  Review of the alterations in DNA methylation in esophageal squamous cell carcinoma.

Authors:  Yoshifumi Baba; Masayuki Watanabe; Hideo Baba
Journal:  Surg Today       Date:  2013-01-05       Impact factor: 2.549

2.  Body mass and DNA promoter methylation in breast tumors in the Western New York Exposures and Breast Cancer Study.

Authors:  Meng-Hua Tao; Catalin Marian; Jing Nie; Christine Ambrosone; Shiva S Krishnan; Stephen B Edge; Maurizio Trevisan; Peter G Shields; Jo L Freudenheim
Journal:  Am J Clin Nutr       Date:  2011-07-20       Impact factor: 7.045

3.  Identification of DNA methylation-driven genes in esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas.

Authors:  Tong Lu; Di Chen; Yuanyong Wang; Xiao Sun; Shicheng Li; Shuncheng Miao; Yang Wo; Yanting Dong; Xiaoliang Leng; Wenxing Du; Wenjie Jiao
Journal:  Cancer Cell Int       Date:  2019-03-06       Impact factor: 5.722

4.  The association between PON1 and GSTM1 genetic variation with methylation of p16 gene promoter among Javanese farmers exposed to pesticides at Magelang Regency, Central Java, Indonesia.

Authors:  Maya G Ratna; Dwi A A Nugrahaningsih; Eti N Sholikhah; Ery K Dwianingsih; Rusdy G Malueka
Journal:  Heliyon       Date:  2020-05-23

Review 5.  The detective, prognostic, and predictive value of DNA methylation in human esophageal squamous cell carcinoma.

Authors:  Kai Ma; Baoping Cao; Mingzhou Guo
Journal:  Clin Epigenetics       Date:  2016-04-22       Impact factor: 6.551

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.